Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Vericiguat by Bayer for Metabolic Syndrome: Likelihood of Approval
Vericiguat is under clinical development by Bayer and currently in Phase II for Metabolic Syndrome. According to GlobalData, Phase II...
Vericiguat by Bayer for Vascular Dysfunction: Likelihood of Approval
Vericiguat is under clinical development by Bayer and currently in Phase II for Vascular Dysfunction. According to GlobalData, Phase II...
Vericiguat by Bayer for Diastolic Heart Failure (HFpEF): Likelihood of Approval
Vericiguat is under clinical development by Bayer and currently in Phase II for Diastolic Heart Failure (HFpEF). According to GlobalData,...